490 related articles for article (PubMed ID: 25039604)
1. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
Blum S; McCombe PA
J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
[TBL] [Abstract][Full Text] [Related]
2. Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
McCombe PA; Csurhes PA; Greer JM
J Neuroimmunol; 2006 Nov; 180(1-2):172-7. PubMed ID: 16935351
[TBL] [Abstract][Full Text] [Related]
3. The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis.
Blum S; Csurhes P; McCombe P
J Neuroimmunol; 2015 Aug; 285():53-6. PubMed ID: 26198918
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
6. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
7. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
8. [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Kanbayashi T; Sonoo M
Brain Nerve; 2015 Nov; 67(11):1388-96. PubMed ID: 26560954
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of CD1 and SH2D2A genes in inflammatory neuropathies.
Uncini A; Notturno F; Pace M; Caporale CM
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():48-51. PubMed ID: 21696499
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Guillain-Barré syndrome and CIDP.
van Doorn PA
J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
[TBL] [Abstract][Full Text] [Related]
11. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis.
McCombe PA; Hardy TA; Nona RJ; Greer JM
Front Immunol; 2022; 13():1038411. PubMed ID: 36569912
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
14. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
Radziwill AJ; Kuntzer T; Steck AJ
Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
[TBL] [Abstract][Full Text] [Related]
15. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Pashenkov M; Jin JP; Link H
J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of lncRNAs in autoimmune neuropathies.
Gholipour M; Taheri M; Mehvari Habibabadi J; Nazer N; Sayad A; Ghafouri-Fard S
Sci Rep; 2021 Aug; 11(1):16061. PubMed ID: 34373511
[TBL] [Abstract][Full Text] [Related]
17. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
Odaka M; Yuki N; Hirata K
J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.
Caporale CM; Papola F; Fioroni MA; Aureli A; Giovannini A; Notturno F; Adorno D; Caporale V; Uncini A
J Neuroimmunol; 2006 Aug; 177(1-2):112-8. PubMed ID: 16820217
[TBL] [Abstract][Full Text] [Related]
19. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Pascual-Pascual SI
Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
[TBL] [Abstract][Full Text] [Related]
20. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]